MMP14 Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Seems to specifically activate progelatinase A. May thus trigger invasion by tumor cells by activating progelatinase A on the tumor cell surface. May be involved in actin cytoskeleton reorganization by cleaving PTK7. Acts as a positive regulator of cell growth and migration via activation of MMP15. Involved in the formation of the fibrovascular tissues in association with pro-MMP2.
Synonyms
Matrix metalloproteinase-14, MMP-X1, Membrane-type matrix metalloproteinase 1, Membrane-type-1 matrix metalloproteinase, MMP-14, MTMMP1, MT1-MMP, MT1MMP, MT-MMP 1
Gene ID
4323
Swiss Prot
P50281
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
MMP14
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
Recombinant human MMP14 between 150 to 250 amino acids
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-52373R-FITC
Gene ID URL
4323
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items